Cannabis and Cannabinoid-Based Medicines in Cancer Care

This book aims to address the multiple challenges facing healthcare providers regarding cannabis-based medicines. The use of cannabis-based medicine (CBM) among cancer patients has risen steadily over the last few years. Offering a practical approach on the use of CBM for cancer patients, this book provides insight into the latest preclinical and clinical data in this rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis’ disease-modifying effects. Part one reviews basic concepts of the endocannabinoid system and pharmacology of CBM, such as the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. Part two then examines the different clinical settings in which CBM may be useful in cancer care. After carefully determining objectives and addressing patient expectations, the book explores specific symptom management, including cancer pain, anxiety, nausea, and insomnia among others.

Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings.

Reviews both regulated and unregulated CBM

Provides prescription recommendations and guidelines for clinical practitioners

Written by experts in the fields of oncology, pain management, and palliative care